Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond native sequence recovery: Improved modeling of the sequence-energy landscape of protein structures.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Multiomic screening platform uncovers the impact of histone mutations on chromatin and cell fate.

bioRxiv : the preprint server for biology·2026
Same author

Discovery and Optimization of Orally Bioavailable Heterobifunctional Degraders of KAT2A/B for the Treatment of Cancer.

Journal of medicinal chemistry·2026
Same author

Beyond native sequence recovery: Improved modeling of the sequence-energy landscape of protein structures.

bioRxiv : the preprint server for biology·2026
Same author

A proteome-wide biochemical screen defines binding determinants of the core autophagy protein LC3B.

bioRxiv : the preprint server for biology·2026
Same author

Design of Specific Peptide Inhibitors of Toxin-Antitoxin-Mediated Antiphage Defense.

ACS synthetic biology·2025

Related Experiment Video

Updated: May 22, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Predictive Bcl-2 family binding models rooted in experiment or structure.

Joe DeBartolo1, Sanjib Dutta, Lothar Reich

  • 1Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Journal of Molecular Biology
|May 24, 2012
PubMed
Summary

Researchers explored Bcl-2 family protein interactions to understand cancer development. They developed models to predict binding specificity, aiding in the design of new cancer therapeutics and diagnostics.

More Related Videos

Single-Molecule Measurement of Protein Interaction Dynamics Within Biomolecular Condensates
06:48

Single-Molecule Measurement of Protein Interaction Dynamics Within Biomolecular Condensates

Published on: January 5, 2024

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Experiment Videos

Last Updated: May 22, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Single-Molecule Measurement of Protein Interaction Dynamics Within Biomolecular Condensates
06:48

Single-Molecule Measurement of Protein Interaction Dynamics Within Biomolecular Condensates

Published on: January 5, 2024

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Biochemistry

Background:

  • Proteins of the Bcl-2 family regulate programmed cell death and are crucial in cancer and chemotherapy resistance.
  • BH3-only proteins initiate cell death by binding to pro-survival Bcl-2 receptors, presenting a molecular recognition challenge due to conserved structures.
  • Understanding Bcl-2 interaction specificity is vital for developing peptide-based cancer therapeutics and diagnostics.

Purpose of the Study:

  • To expand the experimentally tested BH3 sequence space for interactions with five human anti-apoptotic receptors.
  • To identify key protein features determining Bcl-2 family interaction specificity.
  • To develop predictive models for Bcl-2 affinity and specificity.

Main Methods:

  • Utilized peptide SPOT arrays and deep sequencing from yeast display screening to gather interaction data.
  • Constructed two data-based models for predicting affinity and specificity.
  • Developed a novel structure-based statistical potential, STATIUM, for predicting Bcl-2 interactions.

Main Results:

  • Generated extensive data on BH3 sequence space interactions with anti-apoptotic Bcl-2 receptors.
  • The STATIUM model demonstrated remarkable accuracy in predicting Bcl-2 affinity and specificity without experimental training.
  • Compared the performance of data-based and structure-based models, including STATIUM.

Conclusions:

  • The study provides significant insights into the determinants of Bcl-2 family specificity.
  • The developed models, particularly STATIUM, show promise in guiding the prediction and design of novel Bcl-2 family interactions.
  • These findings can accelerate the development of targeted cancer therapeutics and diagnostics.